Literature DB >> 9731786

Is return of angina after coronary artery bypass grafting immutable, can it be delayed, and is it important?

P Sergeant1, E Blackstone, B Meyns.   

Abstract

BACKGROUND: Because survival after either an operation or angioplasty is similar across a wide spectrum of coronary patients, lasting symptom relief assumes high priority.
OBJECTIVES: The objectives of this observational clinical study were (1) to determine whether the return of angina is immutable; (2) to identify factors that might delay its return, and (3) to evaluate whether its return is predictive of subsequent adverse events.
METHODS: The return of angina of any degree of severity and morbid events subsequent to its return were studied by multivariable time-related analyses in a consecutive series of 9600 patients who were undergoing primary isolated coronary bypass operations between 1971 and 1992.
RESULTS: The freedom rate from return of angina was 94%, 82%, 61% and 38% at 1, 5, 10, and 15 years. Increased modest risk of early return of angina was associated with preoperative demographic, symptom, coronary and vascular disease variables but reduced by more extensive arterial grafting. The ever-increasing risk of late return of angina was associated with demographic, symptomatic, left ventricular function, and coronary disease variables and was related strongly to comorbidity but was weakly reduced by controllable surgical variables. After the return of angina, 10-year freedom rate from infarct and survival was 71% and 68% respectively.
CONCLUSIONS: (1) The risk of angina return increases relentlessly after operation, so it is likely immutable. (2) Delay of late angina return by use of arterial grafting is clinically trivial; control of noncardiac comorbidity may be more effective. (3) Fortunately, the return of angina after coronary artery bypass grafting has minimal impact on survival and is not predictive of imminent infarct.

Entities:  

Mesh:

Year:  1998        PMID: 9731786     DOI: 10.1016/S0022-5223(98)70010-8

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  The no-touch vein graft for coronary artery bypass surgery preserves the left ventricular ejection fraction at 16 years postoperatively: long-term data from a longitudinal randomised trial.

Authors:  Benny Johansson; Ninos Samano; Domingos Souza; Lennart Bodin; Derek Filbey; John D Mannion; Leif Bojö
Journal:  Open Heart       Date:  2015-03-24

Review 2.  Diagnostic and Management Strategies in Patients with Late Recurrent Angina after Coronary Artery Bypass Grafting.

Authors:  Ruben W de Winter; Mohammed S Rahman; Pepijn A van Diemen; Stefan P Schumacher; Ruurt A Jukema; Yvemarie B O Somsen; Albert C van Rossum; Niels J Verouden; Ibrahim Danad; Ronak Delewi; Alexander Nap; Paul Knaapen
Journal:  Curr Cardiol Rep       Date:  2022-08-04       Impact factor: 3.955

3.  Use of quantitative cardiovascular magnetic resonance myocardial perfusion mapping for characterization of ischemia in patients with left internal mammary coronary artery bypass grafts.

Authors:  Andreas Seraphim; Kristopher D Knott; Anne-Marie Beirne; Joao B Augusto; Katia Menacho; Jessica Artico; George Joy; Rebecca Hughes; Anish N Bhuva; Ryo Torii; Hui Xue; Thomas A Treibel; Rhodri Davies; James C Moon; Daniel A Jones; Peter Kellman; Charlotte Manisty
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-17       Impact factor: 5.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.